IRF7 and neoplasm: In animals co-injected with irf7 CRISPR, we detected p53EPS tumor formation, albeit with reduced irf7 in and surrounding tumor cells (Figure 4E), suggesting potential roles for irf7 in inhibiting p53EPS initiation in tumor cells and/or within the TME.